Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Fecci

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Cancer Medicine|October 1, 2019
Operative and peri-operative considerations in the management of brain metastasisEric W Sankey, Vadim Tsvankin, Matthew M Grabowski, et al.
Cancer Research|March 17, 2006
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant gliomaPeter E Fecci, Duane A Mitchell, John F Whitesides, et al.
Neuro-Oncology Practice|July 19, 2021
Inpatient palliative care utilization for patients with brain metastasesMeghan Price, Elizabeth P Howell, Tara Dalton, et al.
Neurosurgery|March 21, 2022
Time to Steroid Independence After Laser Interstitial Thermal Therapy vs Medical Management for Treatment of Biopsy-Proven Radiation Necrosis Secondary to Stereotactic Radiosurgery for Brain MetastasisEric W Sankey, Matthew M Grabowski, Ethan S Srinivasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell functionPeter E Fecci, Hidenobu Ochiai, Duane A Mitchell, et al.
Neuro-Oncology Advances|May 19, 2023
Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilegeSelena J Lorrey, Jessica Waibl Polania, Lucas P Wachsmuth, et al.
World Neurosurgery|May 18, 2018
Patterns of Clinical Use of Stereotactic Laser Ablation: Analysis of a Multicenter Prospective RegistryRobert C Rennert, Usman Khan, Stephen B Tatter, et al.
Advances in Radiation Oncology|November 24, 2022
Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain MetastasesEmily C Lerner, Ethan S Srinivasan, Gloria Broadwater, et al.
Immunotherapy|September 19, 2019
Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memoryYang Liu, Pakawat Chongsathidkiet, Bridget M Crawford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2025
Adapting Laser Interstitial Thermal Therapy (LITT) for the Treatment of Naturally Occurring Intracranial Tumors in DogsChristopher L Mariani, Lucas P Wachsmuth, Alexa N Bramall, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Cancer Medicine|October 1, 2019
Operative and peri-operative considerations in the management of brain metastasisEric W Sankey, Vadim Tsvankin, Matthew M Grabowski, et al.
Cancer Research|March 17, 2006
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant gliomaPeter E Fecci, Duane A Mitchell, John F Whitesides, et al.
Neuro-Oncology Practice|July 19, 2021
Inpatient palliative care utilization for patients with brain metastasesMeghan Price, Elizabeth P Howell, Tara Dalton, et al.
Neurosurgery|March 21, 2022
Time to Steroid Independence After Laser Interstitial Thermal Therapy vs Medical Management for Treatment of Biopsy-Proven Radiation Necrosis Secondary to Stereotactic Radiosurgery for Brain MetastasisEric W Sankey, Matthew M Grabowski, Ethan S Srinivasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell functionPeter E Fecci, Hidenobu Ochiai, Duane A Mitchell, et al.
Neuro-Oncology Advances|May 19, 2023
Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilegeSelena J Lorrey, Jessica Waibl Polania, Lucas P Wachsmuth, et al.
World Neurosurgery|May 18, 2018
Patterns of Clinical Use of Stereotactic Laser Ablation: Analysis of a Multicenter Prospective RegistryRobert C Rennert, Usman Khan, Stephen B Tatter, et al.
Advances in Radiation Oncology|November 24, 2022
Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain MetastasesEmily C Lerner, Ethan S Srinivasan, Gloria Broadwater, et al.
Immunotherapy|September 19, 2019
Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memoryYang Liu, Pakawat Chongsathidkiet, Bridget M Crawford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2025
Adapting Laser Interstitial Thermal Therapy (LITT) for the Treatment of Naturally Occurring Intracranial Tumors in DogsChristopher L Mariani, Lucas P Wachsmuth, Alexa N Bramall, et al.
Pageof 12